Lgi1 Autoimmune Encephalitis

Top drugs studied for this disease

All Approvals Safety alerts Label changes Trial results Research Guidance Withdrawals

CLINICAL_TRIALS research · 2026-04-03
Clinical Trial Update: A Study to Evaluate the Efficacy, Safety, Pharmacokinetics (PK), and Pharmacodynamics (PD) of Satralizumab in Participants With Anti-N-methyl-D-aspartic Acid Receptor (NMDAR) or Anti-leucine-rich Glioma-inactivated 1 (LGI1) Encephalitis [Phase 3]
A Phase 3 clinical trial evaluating the efficacy, safety, pharmacokinetics, and pharmacodynamics of satralizumab in participants with anti-N…
CLINICAL_TRIALS trial_result · 2025-05-31
Clinical Trial Update: A Study to Test the Efficacy, Safety, and Pharmacokinetics of Rozanolixizumab in Adult Study Participants With Leucine-Rich Glioma Inactivated 1 Autoimmune Encephalitis [Phase 2]
Phase 2 study of Rozanolixizumab in adults with LGI1 autoimmune encephalitis was terminated; results have been posted.